U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07302269) titled 'Study of the Safety, Tolerability, Pharmacokinetics of VV261 Tablets in Chinese Healthy Volunteers' on Dec. 11.
Brief Summary: This is a randomized, double-blind, placebo-controlled, single ascending-dose study to evaluate the safety, tolerability and pharmacokinetics characteristics of VV261 tablets in healthy adults.
Study Start Date: Dec. 31
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: VV261 5mg group
2 subjects will receive VV261 5mg, orally
DRUG: VV261 20mg Group
6 subjects receive VV261 20mg,orally; 2 subjects will receive placebo,orally.
DRUG: VV261 50mg group
6 subjects receive VV26...